|
C14ORF106 expression based on
|
KIRP : Kidney renal papillary cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.912800E-01 |
|
KIRP : Kidney renal papillary cell carcinoma Note
Cancer stage information is not available for 89 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
5.624000E-02 |
| Normal-vs-Stage2 |
8.787200E-01 |
| Normal-vs-Stage3 |
8.798000E-01 |
| Normal-vs-Stage4 |
5.625800E-01 |
| Stage1-vs-Stage2 |
1.461430E-01 |
| Stage1-vs-Stage3 |
1.878250E-01 |
| Stage1-vs-Stage4 |
6.744600E-01 |
| Stage2-vs-Stage3 |
8.005400E-01 |
| Stage2-vs-Stage4 |
5.614200E-01 |
| Stage3-vs-Stage4 |
7.032800E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient race information is not available for 15 samples and two samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.998210E-01 |
| Normal-vs-AfricanAmerican |
8.035800E-01 |
| Normal-vs-Asian |
5.122000E-01 |
| Caucasian-vs-AfricanAmerican |
3.804000E-01 |
| Caucasian-vs-Asian |
3.924200E-01 |
| AfricanAmerican-vs-Asian |
5.770600E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
9.696200E-02 |
| Normal-vs-Female |
1.710810E-01 |
| Male-vs-Female |
5.300000E-03 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient BMI information is not available for 72 samples.
| Descriptions |
| Normal weight |
BMI greater than equal to 18.5 and BMI less than 25 |
Extereme weight |
BMI greater than equal to 25 and BMI less than 30 |
| Obese |
BMI greater than equal to 30 and BMI less than 40 |
Extreme Obese |
BMI greater than 40 |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Normal_Weight |
2.034000E-01 |
| Normal-vs-Extreme_Weight |
8.681500E-03 |
| Normal-vs-Obese |
6.629200E-01 |
| Normal-vs-Extreme_Obese |
3.491700E-02 |
| Normal_Weight-vs-Extreme_Weight |
2.284600E-01 |
| Normal_Weight-vs-Obese |
1.180960E-01 |
| Normal_Weight-vs-Extreme_Obese |
3.482800E-01 |
| Extreme_Weight-vs-Obese |
6.797500E-03 |
| Extreme_Weight-vs-Extreme_Obese |
7.237400E-01 |
| Obese-vs-Extreme_Obese |
2.159800E-02 |
|
|
KIRP : Kidney renal papillary cell carcinoma Note
Patient age information is not available for 3 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
2.310600E-01 |
| Normal-vs-Age(41-60Yrs) |
8.534000E-01 |
| Normal-vs-Age(61-80Yrs) |
1.010560E-01 |
| Normal-vs-Age(81-100Yrs) |
1.792050E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.044400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
8.799700E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.212100E-02 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.722500E-02 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
8.278300E-03 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
1.280630E-01 |
|
|
KIRP : Kidney renal papillary cell carcinoma NOTE
Histology information is not available for 17 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-VS-Type1 PRCC |
7.688200E-02 |
| Normal-VS-Type2 PRCC |
6.876500E-02 |
| Normal-VS-KIRP CIMP |
1.972240E-01 |
| Normal-VS-Unclassified PRCC |
1.676810E-01 |
| Type1 PRCC-VS-Type2 PRCC |
6.295600E-01 |
| Type1 PRCC-VS-KIRP CIMP |
1.047350E-01 |
| Type1 PRCC-VS-Unclassified PRCC |
1.604110E-02 |
| Type2 PRCC-VS-KIRP CIMP |
9.390100E-02 |
| Type2 PRCC-VS-Unclassified PRCC |
1.231860E-02 |
| KIRP CIMP-VS-Unclassified PRCC |
3.522200E-01 |
|
Histologic PRCC subtypes: Ricketts CJ et al, The Cancer Genome Atlas Comprehensive Molecular Characterization of Renal Cell Carcinoma. Cell Rep. 2018 Apr 3;23(1):313-326.e5. doi: 10.1016/j.celrep.2018.03.075
|
KIRP : Kidney renal papillary cell carcinoma Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 211 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
3.182300E-02 |
| Normal-vs-N1 |
1.201620E-01 |
| Normal-vs-N2 |
2.539900E-02 |
| N0-vs-N1 |
1.155810E-02 |
| N0-vs-N2 |
3.176600E-01 |
| N1-vs-N2 |
1.083820E-01 |
|
|
